Cargando…

Pro-brain natriuretic peptide as a marker of successful thrombolysis in patients with submassive pulmonary thromboembolism

Detalles Bibliográficos
Autores principales:	Castro, R, Andresen, M, Ruiz, C, Gonzalez, A, Diaz, O, Mercado, M, Meneses, L, Fava, M, Cordova, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4088813/ http://dx.doi.org/10.1186/cc6663

Ejemplares similares

Submassive pulmonary thromboembolism, post-COVID sequelae; with mechanical thrombus aspiration and accelerated thrombolysis by Ekos ultrasound with successful resolution
por: Benitez, J., et al.
Publicado: (2022)

Thrombolysis treatment for submassive pulmonary thromboembolism in patients with cancer: a safe therapeutic tool
por: de Almeida, Juliano Pinheiro, et al.
Publicado: (2011)

Impact of Oral Thrombolysis After Catheter-based Thrombectomy in Acute and Subacute Submassive Pulmonary Thromboembolism
por: Ahmed, Khurshid, et al.
Publicado: (2015)

Low-dose thrombolysis for submassive pulmonary embolism
por: Yilmaz, Emine Serap, et al.
Publicado: (2021)

Successful low-dose thrombolysis of submassive pulmonary embolus in a pregnant patient
por: Dhutia, Harshil, et al.
Publicado: (2014)

Clinical outcomes of submassive pulmonary embolism thrombolysis—an Indian experience
por: Rehman, Nadeem U., et al.
Publicado: (2020)

Catheter-Directed Thrombolysis for Submassive Pulmonary Embolism in the Third Trimester of Pregnancy
por: Compadre, Amanda J., et al.
Publicado: (2020)

Catheter-directed therapy for submassive pulmonary embolism after unsuccessful systemic thrombolysis
por: Dong, Chang, et al.
Publicado: (2017)

Submassive Pulmonary Thromboembolism in a Patient with Thrombocytopenia: Therapeutic Challenge
por: Muñoz Tovar, Ronni Andrea, et al.
Publicado: (2019)

Apixaban or Rivaroxaban Versus Warfarin for Treatment of Submassive Pulmonary Embolism After Catheter-Directed Thrombolysis
por: Groetzinger, Lara M., et al.
Publicado: (2018)

Systematic review and meta-analysis for thrombolysis treatment in patients with acute submassive pulmonary embolism
por: Cao, Yaoqian, et al.
Publicado: (2014)

Lifting the fog in intermediate-risk (submassive) PE: full dose, low dose, or no thrombolysis?
por: Bhamani, Amyn, et al.
Publicado: (2019)

A systematic review for the role of systemic thrombolysis in intermediate-risk (submassive) pulmonary embolism
por: Seif, Mohamed Ahmed
Publicado: (2020)

Successful treatment of submassive pulmonary embolism with right ventricle strain using ultrasound-assisted thrombolysis with urokinase: a case report
por: Al-Terki, Hani, et al.
Publicado: (2023)

Impact of introducing guidelines for thrombolysis of submassive pulmonary embolism at a large UK teaching hospital
por: Misselbrook, GP
Publicado: (2015)

Catheter-directed Thrombolysis versus Systemic Anticoagulation for Submassive Pulmonary Embolism: A Meta-Analysis
por: Siordia, Juan Arturo, et al.
Publicado: (2022)

N-Terminal Pro-brain Natriuretic Peptide Is Associated With Hemorrhagic Transformation and Poor Outcomes in Patients With Stroke Treated With Intravenous Thrombolysis
por: Zhang, Ke-Jia, et al.
Publicado: (2021)

Unloading of Right Ventricle and Clinical Improvement after Ultrasound-Accelerated Thrombolysis in Patients with Submassive Pulmonary Embolism
por: Jain, Sachin Kumar Amruthlal, et al.
Publicado: (2014)

Outcomes of catheter-directed thrombolysis vs. standard medical therapy in patients with acute submassive pulmonary embolism
por: D’Auria, Stephen, et al.
Publicado: (2020)

Successful selective arterial thrombolysis in patient with acute abdominal thromboembolism
por: Tsekov, Christo, et al.
Publicado: (2016)

Dramatic Normalization of the Echocardiographic Pulmonary–to–Left Atrial Ratio with Thrombolysis in a Case of Life-Threatening Submassive Pulmonary Emboli
por: Scalia, Isabel G., et al.
Publicado: (2017)

Utility of point-of-care testing of natriuretic peptides (brain natriuretic peptide and n-terminal pro-brain natriuretic peptide) in the emergency department
por: Nayer, Jamshed, et al.
Publicado: (2014)

Tissue plasminogen activator dose and pulmonary artery pressure reduction in catheter directed thrombolysis of submassive pulmonary embolism
por: Patel, Darshan C., et al.
Publicado: (2019)

A Case of Klippel-Trenaunay Syndrome with Acute Submassive Pulmonary Thromboembolism Treated with Thrombolytic Therapy
por: Chu, Seong-Taek, et al.
Publicado: (2015)

Systemic thrombolysis for acute submassive pulmonary embolism after laparoscopic Roux-en-Y bypass: A case report
por: Brañes, Alejandro, et al.
Publicado: (2019)

Feasibility and safety of catheter-directed thrombolysis via superficial cubital vein for the treatment of acute massive and submassive pulmonary embolism
por: Giunio, Lovel, et al.
Publicado: (2021)

Submassive Pulmonary Embolism Treated With Catheter-Directed Thrombolysis in Resource-Limited Setting: A Case Report and Review of Literature
por: Gurjar, Hitesh, et al.
Publicado: (2022)

Successful Point-Of-Care Ultrasound-Guided Treatment of Submassive Pulmonary Embolism
por: Myers, Samantha J., et al.
Publicado: (2017)

B-type natriuretic peptide versus amino terminal pro-B type natriuretic peptide: selecting the optimal heart failure marker in patients with impaired kidney function
por: Jafri, Lena, et al.
Publicado: (2013)

Artificial Intelligence-Enabled Electrocardiography Detects B-Type Natriuretic Peptide and N-Terminal Pro-Brain Natriuretic Peptide
por: Liu, Pang-Yen, et al.
Publicado: (2023)

Atrial Fibrillation, thromboembolic risk, and the potential role of the natriuretic peptides, a focus on BNP and NT-proBNP – A narrative review
por: Kerr, Brian, et al.
Publicado: (2022)

N-terminal pro atrial natriuretic peptide as a prognostic marker of cardiac resynchronization therapy recipients
por: Ueda, Nobuhiko, et al.
Publicado: (2023)

NH(2)-Terminal Pro–Brain Natriuretic Peptide and Risk of Diabetes
por: Lazo, Mariana, et al.
Publicado: (2013)

N-terminal Pro-Brain Natriuretic Peptide And Atrial Fibrillation
por: Thejus, Jayachandran, et al.
Publicado: (2009)

Effect of Pancreatic Hormones on pro-Atrial Natriuretic Peptide in Humans
por: Zois, Nora E., et al.
Publicado: (2017)

Pro-atrial natriuretic peptide in patients with sepsis, severe sepsis and septic shock
por: Prucha, M, et al.
Publicado: (2005)

B-type natriuretic peptide and N-terminal Pro-B-type natriuretic peptide in severe aortic stenosis: a comprehensive literature review
por: Cavalcante, Pâmela Nogueira, et al.
Publicado: (2023)

Midregional pro-atrial natriuretic peptide, an important member of the natriuretic peptide family: potential role in diagnosis and prognosis of cardiovascular disease
por: Idzikowska, Karolina, et al.
Publicado: (2018)

Analysis of the B-Type Natriuretic Peptide and the Aminoterminal-Pro-B-Type Natriuretic Peptide in Different Parrot, Raptor and Owl Species
por: Hennig, Anja, et al.
Publicado: (2022)

N‐Terminal Pro‐C‐Natriuretic Peptide and Cytokine Kinetics in Dogs with Endotoxemia
por: Floras, A.N.K., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_i3drfd79h1l9jgf50k4vp4ma4f